Lunai Bioworks Inc.
LNAI
$1.02
-$0.15-12.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 17.88M | 18.88M | 22.31M | 21.57M | 24.56M |
| Depreciation & Amortization | 129.10K | 127.60K | 125.90K | 127.00K | 121.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.55M | 19.90M | 24.50M | 24.23M | 27.39M |
| Operating Income | -18.55M | -19.90M | -24.50M | -24.23M | -27.39M |
| Income Before Tax | -178.01M | -67.01M | -126.19M | -123.46M | -88.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -178.01 | -67.01 | -126.19 | -123.46 | -88.43 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -178.01M | -67.01M | -126.19M | -123.46M | -88.43M |
| EBIT | -18.55M | -19.90M | -24.50M | -24.23M | -27.39M |
| EBITDA | -18.42M | -19.77M | -24.38M | -24.10M | -27.27M |
| EPS Basic | -10.46 | -4.30 | -9.71 | -9.95 | -8.55 |
| Normalized Basic EPS | -0.73 | -0.88 | -1.23 | -1.48 | -2.12 |
| EPS Diluted | -10.46 | -4.31 | -9.72 | -9.96 | -8.56 |
| Normalized Diluted EPS | -0.73 | -0.88 | -1.23 | -1.48 | -2.12 |
| Average Basic Shares Outstanding | 65.68M | 63.15M | 57.84M | 48.25M | 39.04M |
| Average Diluted Shares Outstanding | 65.84M | 63.31M | 57.84M | 48.25M | 39.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |